Ajit Vikram
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Carcinogens and Genotoxicity Assessment
- Geriatrics and Gerontology top 5%
Papers in ⓘ
-
- Carcinogens and Genotoxicity Assessment 11
- MicroRNA in disease regulation 8
- Urology 7
- Urinary Bladder and Prostate Research 7
- Co-authors
- Gopabandhu Jena (28 shared papers)Poduri Ramarao (20 shared papers)Durga Nand Tripathi (16 shared papers)Kaikobad Irani (19 shared papers)Young‐Rae Kim (16 shared papers)Anisha Gupta (2 shared papers)Santosh Kumar (12 shared papers)Karishma Dhuri (4 shared papers)
- Journals
- Mutation Research/Genetic Toxicology and Environmental Mutagenesis (6 papers)Biochemical and Biophysical Research Communications (4 papers)Scientific Reports (3 papers)European Journal of Pharmacology (3 papers)Regulatory Toxicology and Pharmacology (3 papers)
- Partner nations
- IndiaUnited StatesSouth Korea
In The Last Decade
Ajit Vikram
61 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Cancer Research 477
- Geriatrics and Gerontology 83
- Urology 136
- Endocrinology, Diabetes and Metabolism 267
- Molecular Biology 1.1k
Countries citing papers authored by Ajit Vikram
This map shows the geographic impact of Ajit Vikram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajit Vikram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajit Vikram more than expected).
Fields of papers citing papers by Ajit Vikram
This network shows the impact of papers produced by Ajit Vikram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajit Vikram. The network helps show where Ajit Vikram may publish in the future.
Co-authors
The 25 scholars most cited alongside Ajit Vikram, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development Hit paper breakdown → | 2020 | 368 |
| 2 | 2013 | 104 | |
| 3 | 2016 | 101 | |
| 4 | 2009 | 97 | |
| 5 | 2017 | 97 | |
| 6 | 2008 | 93 | |
| 7 | 2009 | 76 | |
| 8 | 2016 | 71 | |
| 9 | 2010 | 70 | |
| 10 | 2008 | 64 | |
| 11 | 2021 | 63 | |
| 12 | 2016 | 61 | |
| 13 | 2010 | 58 | |
| 14 | 2014 | 54 | |
| 15 | 2014 | 52 | |
| 16 | 2009 | 50 | |
| 17 | 2011 | 45 | |
| 18 | 2017 | 39 | |
| 19 | 2013 | 38 | |
| 20 | 2007 | 35 |
About Ajit Vikram
Ajit Vikram is a scholar working on Cancer Research, Urology, Geriatrics and Gerontology, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 61 papers that have together received 2.2k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (11 papers), MicroRNA in disease regulation (8 papers), Urinary Bladder and Prostate Research (7 papers), Adipose Tissue and Metabolism (7 papers), RNA Interference and Gene Delivery (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Hormonal and reproductive studies (5 papers) and Effects and risks of endocrine disrupting chemicals (4 papers). The work is most often cited by research in Cancer Research (477 citations), Geriatrics and Gerontology (83 citations), Urology (136 citations), Endocrinology, Diabetes and Metabolism (267 citations) and Molecular Biology (1.1k citations). Ajit Vikram has collaborated with scholars based in India, United States and South Korea. Frequent co-authors include Gopabandhu Jena, Poduri Ramarao, Durga Nand Tripathi, Kaikobad Irani, Young‐Rae Kim, Anisha Gupta, Santosh Kumar, Karishma Dhuri, Raman Bahal and Hà Phạm. Their work appears in journals such as Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Biochemical and Biophysical Research Communications, Scientific Reports, European Journal of Pharmacology and Regulatory Toxicology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.